Aurelia Healthcare — Project Overview
The platform architecture and the three-phase build — Aurelia Medical City in Johannesburg, regional specialist hospitals and the integrated healthcare ecosystem — and the platform scale at stabilization.
Section 2 · Business Plan
Project Overview
The platform architecture and the three-phase build — Aurelia Medical City in Johannesburg, regional specialist hospitals and the integrated healthcare ecosystem — and the platform scale at stabilization.
2.1 Platform Architecture
Aurelia Healthcare Group will be developed as a three-phase, ten-year
capital programme designed to assemble a defensible,
geographically-diversified, clinically-integrated platform. The phasing
approach allows capital to be deployed in disciplined tranches with
clear go/no-go gates, while creating early operational cash flow from
the flagship facility to partially de-risk subsequent phases.
2.2 Phase I — Aurelia Medical City, Johannesburg (Years 1–3)
The flagship development is conceived as a world-class integrated
academic medical city located in the Sandton-Modderfontein corridor —
South Africa’s densest concentration of insured population,
multinational corporate headquarters, and tertiary specialist
clinicians. Site selection prioritises proximity to the M1 highway, OR
Tambo International Airport (medical tourism corridor), and
complementary tertiary infrastructure.
Phase I — Facility Composition
| Component | Specification | Capex (USD M) |
|---|---|---|
| Tertiary Inpatient Hospital | 420 acute beds (incl. 60 ICU/HDU) | 78.0 |
| Operating Theatre Suite | 18 theatres (incl. 2 hybrid OR, 4 robotic-ready) | 14.5 |
| Level 1 Trauma & Emergency Centre | 24/7 trauma bays, helipad, CT-in-resus | 8.5 |
| Cardiac Institute | Cath labs, EP suite, structural heart programme | 11.0 |
| Oncology Institute | Linac vault (×3), brachytherapy, day chemo | 12.5 |
| Women & Children’s Hospital | 60 maternity beds, NICU, paeds ICU | 7.0 |
| Renal & Transplant Centre | 30-station dialysis, transplant theatre | 4.5 |
| Diagnostic Imaging Hub | 3T MRI ×2, CT ×3, PET-CT, DEXA, fluoroscopy | 6.0 |
| Teaching & Simulation Centre | High-fidelity simulators, lecture halls | 2.5 |
| Land, civils, soft costs, contingency | 0.5 | |
| Total Phase I Capex | 145.0 |
2.3 Phase II — Regional Specialist Hospitals (Years 3–5)
Phase II extends the platform into three further metropolitan
markets, leveraging the brand equity, clinical protocols, technology
backbone, and back-office shared services of the Johannesburg flagship
to drive faster ramp-up and superior unit economics. Site selection is
informed by gravity modelling against insured population density,
specialist supply gaps, and competitor catchment overlap.
| Facility | Beds | Theatres | Specialty Focus | Capex (USD M) |
|---|---|---|---|---|
| Cape Town Specialist Hospital (Century City / Tygervalley) | 150 | 12 | Cardiac, oncology, orthopaedic | 26.0 |
| Durban Specialist Hospital (Umhlanga / Ridgeside) | 140 | 11 | Trauma, cardiac, hepatobiliary | 23.0 |
| Pretoria Medical Centre (Menlyn / Waterkloof) | 160 | 10 | Government corporate, oncology, women’s health | 23.0 |
| Phase II Total | 450 | 33 | 72.0 |
2.4 Phase III — Integrated Healthcare Ecosystem (Years 5–8)
The ecosystem build-out converts Aurelia from a hospital group into
an integrated healthcare platform, capturing patient flow upstream
(primary care, screening) and downstream (rehabilitation, chronic care,
telehealth) of the acute episode. The strategic rationale is threefold:
(i) lower customer acquisition cost via owned referral channels; (ii)
higher lifetime value per patient through longitudinal continuity; and
(iii) defensive moat against NHI fee compression by capturing service
margin across the care pathway.
- Outpatient & Day-Hospital Network: 14 sites
in metropolitan and growth-corridor locations, branded under “Aurelia
Care”, offering same-day surgery, outpatient consults, minor procedures,
and preventative health. - Dialysis Network: 11 dedicated dialysis centres
co-located with high-density renal-failure catchments, contracted to
medical schemes and (subject to accreditation) NHI from
inception. - Oncology Satellite Clinics: 6 satellite
chemotherapy and infusion centres operating under hub-and-spoke clinical
governance from the flagship Oncology Institute. - Diagnostic Laboratories: Joint-venture pathology
and molecular diagnostics laboratories with one of the established South
African pathology majors, embedded in the EMR for closed-loop result
reporting. - Telemedicine & Digital Health: AurelaConnect
platform offering scheduled and on-demand telehealth, e-prescriptions,
remote chronic-disease monitoring, and behavioural-health
programmes. - AI-Enabled Radiology: Cloud-based AI triage and
reporting for stroke, pulmonary embolism, intracranial haemorrhage,
fracture, and breast-cancer screening, deployed across all in-network
imaging. - Occupational Healthcare Contracts: Site-based
occupational health services for major mining, manufacturing, and
corporate clients, embedded with a corporate wellness offering.
2.5 Platform Scale at Stabilization
At full stabilization in Year 6+, the platform will operate at the
following scale, positioning Aurelia as the credible “fourth force” in
South African private hospital services and the most digitally-mature
operator in the market.
| Metric | Phase I Stabilized | Phase II Stabilized | Group at Stabilization |
|---|---|---|---|
| Total Beds | 420 | 450 | 870 |
| ICU / HDU Beds | 60 | 85 | 145 |
| Operating Theatres | 18 | 33 | 51 |
| Linear Accelerators | 3 | 2 | 5 |
| Dialysis Stations | 30 | 48 | 78 (+ 220 in network) |
| Annual Patient Interactions | 0.42 M | 1.08 M | 1.5 M+ |
| Total Workforce | 2,400 | 3,800 | 7,360 |
| Affiliated Doctors | 350 | 430 | 780+ |
| Outpatient Sites (network) | 0 | 0 | 14 |
| Diagnostic Sites (network) | 1 | 3 | 8 |
Confidential — this business plan is provided to prospective investors and lenders for evaluation purposes only and may not be reproduced or distributed without the written consent of Aurelia Healthcare Holdings (Pty) Ltd.